Immune checkpoint inhibitor-induced myocarditis and multiple adverse events with pre-existing rheumatoid arthritis: a case report and literature review.
Kachi S, Shirakashi M, Nomizo T, Onishi M, Toda Kato E, Nobashi TW, Onizawa H, Hiwa R, Tsuji H, Akizuki S, Nakashima R, Onishi A, Yoshifuji H, Tanaka M, Murakami K, Morinobu A.
Immunol Med. 2025 Dec;48(4):400-406. doi: 10.1080/25785826.2025.2515688. Epub 2025 Jun 5.
PMID:40471689
Neutrophil Extracellular Traps (NETs) in health and disease.
Shahzad A, Ni Y, Yang Y, Liu W, Teng Z, Bai H, Liu X, Sun Y, Xia J, Cui K, Duan Q, Xu Z, Zhang J, Yang Z, Zhang Q.
Mol Biomed. 2025 Dec 3;6(1):130. doi: 10.1186/s43556-025-00337-9.
Myocarditis in connective tissue diseases: an often-overlooked clinical manifestation.
Azzam M, Awad A, Abugharbyeh A, Kahaleh B.
Rheumatol Int. 2023 Nov;43(11):1983-1992. doi: 10.1007/s00296-023-05428-w. Epub 2023 Aug 16.
PMID:37587233
Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events.
Fa'ak F, Buni M, Falohun A, Lu H, Song J, Johnson DH, Zobniw CM, Trinh VA, Awiwi MO, Tahon NH, Elsayes KM, Ludford K, Montazari EJ, Chernis J, Dimitrova M, Sandigursky S, Sparks JA, Abu-Shawer O, Rahma O, Thanarajasingam U, Zeman AM, Talukder R, Singh N, Chung SH, Grivas P, Daher M, Abudayyeh A, Osman I, Weber J, Tayar JH, Suarez-Almazor ME, Abdel-Wahab N, Diab A.